Advance Agrolife Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
ADVANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Advance Agrolife Limited filed its quarterly statement on utilization of IPO proceeds for Q4 FY26 (quarter ended March 31, 2026). The company raised Rs. 1,928.42 million through its Initial Public Offer (IPO), which was completed on October 6, 2025, with listing on BSE and NSE on October 8, 2025. The monitoring agency, Care Ratings Limited, has confirmed there is no deviation or variation in the use of IPO funds as against the originally disclosed objects. Both the Audit Committee and auditors have provided nil comments, indicating clean utilization of proceeds as planned.
No deviation in IPO fund utilization is a positive signal, indicating the company is executing its stated objectives as per the prospectus. Shareholders can view this as compliance with capital deployment commitments, though no major price catalyst is expected from this routine filing.